Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for reducing antipsychotic-associated weight gain in schizophrenia
TCTR20160907002Phase 4Recruiting
- Sponsor
- Faculty of Medicine, Khon Kaen University
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in schizophrenia, sponsored by Faculty of Medicine, Khon Kaen University. Started Aug 2016; status: recruiting.
02
Drugs
melatonin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on TCTR20160907002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160907002.